Evaluation of cannabinoid eye drops on five patients with intractable hypertensive open angle glaucoma


Evaluation of cannabinoid eye drops on five patients with intractable hypertensive open angle glaucoma

The aim of the present work was the evaluation of a topic application of cannabinoids in 5 patients affected by late stage open angle glaucoma (OAG) in which both surgical and medical therapies had failed to decrease the intraocular pressure (IOP) to acceptable levels, and were not suitable to further surgical intervention. Eye drops were formulated with Bediol (containing low amounts of tetrahydrocannabinol [THC] and cannabidiol [CBD]), and with Bedrocan (containing higher amounts of THC and lower amounts of CBD). Patients were treated first with Bediol eye drops for 30 days, and after a one-month washout period, they were treated with Bedrocan eye drops for a further 30 days. Four patients did not show any response to both products, while a fifth patient, affected by glaucoma secondary to Fuchs heterochromic iridocyclitis (a rare form of uveitis), showed a relevant antinflammatory effect and IOP decrease in the affected eye. These results suggest a use of THC as an antinflammatory agent in cases of glaucoma secondary to inflammatory events.

Full text in https://www.pulsus.com/scholarly-articles/evaluation-of-cannabinoid-eye-drops-on-five-patients-with-intractable-hypertensive-open-angle-glaucoma.pdf

The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication. A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing.

Manuscripts can be uploaded directly through mail id: ophthalmologist@eclinicalsci.com or forwarded to the Editorial Office at https://www.pulsus.com/ophthalmologist-clinical-therapeutic-journal.html

Media Contact:
Sarah Rose
Journal Manager
The Ophthalmologist: Clinical and Therapeutic Journal
Email: ophthalmologist@eclinicalsci.com